[PDF] snmjournals.org

[PDF][PDF] SNMMI procedure standard/EANM practice guideline for SSTR PET: imaging neuroendocrine tumors

TA Hope, M Allen-Auerbach, L Bodei… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Somatostatin receptor (SSTR) imaging using PET has replaced scintigraphic imaging using
111In-pentetreotide (OctreoScan), unless PET is unavailable. Several benefits of SSTR PET
compared with 111In-pentetreotide have driven this change: improved sensitivity of lesion
detection; lower radiation dose; and shorter and more convenient study duration. Three
SSTR PET radiotracers are currently available: 68Ga-DOTATATE approved by the Food and
Drug Administration (FDA) in 2016, 68Ga-DOTATOC approved by the European Medicines …
被引用次数：33 相关文章 所有 12 个版本
[PDF] amazonaws.com

[PDF][PDF] SNMMI Procedure Standard/EANM Practice Guideline for SSTR Receptor PET: Imaging Neuroendocrine Tumors

TA Hope, M Allen-Auerbach, L Bodei, J Calais… - rdcms-snmmi.s3.amazonaws.com
Somatostatin Receptor (SSTR) imaging using Positron Emission Tomography (PET) has
replaced scintigraphic imaging using 111In-pentetreotide (OctreoScan), unless PET is
unavailable. Several benefits of SSTR-PET compared to 111In-pentetreotide have driven
this change: improved sensitivity of lesion detection; lower radiation dose; and shorter and
more convenient study duration. Three SSTR-PET radiotracers are currently available:
gallium-68 (68Ga)-DOTATATE approved by the FDA in 2016, 68Ga-DOTATOC approved by …
相关文章
以上显示的是最相近的搜索结果。 查看全部搜索结果